PhD/MD Curriculum in cooperation with the University Tuebingen
The PhD/MD curriculum complements the scientific training of the PhD/MD students in the individual research groups at the IKP and the RBCT. It consists of weekly seminars over a period of 3 years (6 semesters) covering essential content from experimental and clinical pharmacology, biochemistry, physiology, pathophysiology of selected diseases, statistics, clinical trials, ethics and law in clinical trials, and other key topics. Further, the PhD/MD curriculum also comprises aspects of career planning, technology transfer and good scientific practice. Senior scientists from the IKP, the RBK, and the RBCT give lectures according to their respective expertise. For topics for which no in-house expertise is available (e.g. technology transfer, perspectives from industry, ethics and law), external guests are invited to share their knowledge with the students.
Running schedule
Winter Semester 2026 / 2027
Focus on Translational research at IKP, RBCT and RBIM
21.10.2026 D. Saul (RBCT); The curious case of the SASP in cellular senescence and cancer |
11.11.2026 H. Horn/C. Kalla (IKP/RBK); PharmacoOmics & lymphoma |
25.11.2026 H. Yun (RBCT); Transcription in chaos: How gene mutations fuel leukemia |
02.12.2026 T. Mürdter/M. Dong (IKP); Microphysiological tissue models of solid cancer and microenvironment |
16.12.2026 W. Ge (RBCT); Omics technologies and computational tools for translational research |
20.01.2027 V. Lauschke (IKP); Microphysiological tissue models of metabolic disease |
03.02.2027 H. Cramer (RBIM); Research in Integrative Medicine: Characteristics, patterns, methodology |
10.02.2027 W. Schroth/F. Büttner (IKP); Breast cancer recurrence and clinical translation |
24.02.2027 S. Beyes (RBCT); Targeting mitotic vulnerabilities in breast cancer |
03.03.2027 R.Tremmel/E. Schäffeler/ R. Bohnert/ M. Schwab (IKP); Clinical pharmacogenomics, metabolism and cancer |